Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 3;10(7):797. doi: 10.3390/bioengineering10070797

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

DCI and no-DCI prediction results for specific patient cases of using nimodipine combined with cilostazol (ground truth was no DCI) or nimodipine only. (A.1) DCI prediction result for both nimodipine and cilostazol used together. (A.2) Risk factors contributing to the feature value. (A.3) Local explanation graph for the patient. (B.1) DCI prediction result for nimodipine used only. (B.2) Contributing risk factors in the feature value. (B.3) Local explanation graph for the patient. Angio_Vaso: angiographic vasospasm, Tx_method: treatment method, Aneurysm_Loc: aneurysm location, HH_Excel: good Hunt–Hess grade (1 and 2) or bad grade (3, 4, and 5), and Aneurysm_Sz: aneurysm size, same as others in Table 1.